Nicolas Girard , Qingqing Xu , D. Ross Camidge , Shobhit Baijal , Sudeep Karve , Sophia Ng , Rajesh Kamalakar , Christine Ratajczak , Allison Allen , Shun Lu
{"title":"PP01.58 接受二线或三线多西他赛治疗的表皮生长因子受体野生型非鳞癌局部晚期/转移性 NSCLC 患者的真实世界结果:来自 LUMINATE-101 的汇总分析","authors":"Nicolas Girard , Qingqing Xu , D. Ross Camidge , Shobhit Baijal , Sudeep Karve , Sophia Ng , Rajesh Kamalakar , Christine Ratajczak , Allison Allen , Shun Lu","doi":"10.1016/j.jtho.2024.05.293","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":null,"pages":null},"PeriodicalIF":21.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PP01.58 Real-world Outcomes in Patients With EGFR Wildtype Non-squamous Locally Advanced/Metastatic NSCLC Receiving Second- or Third-Line Docetaxel: Pooled Analysis From LUMINATE-101\",\"authors\":\"Nicolas Girard , Qingqing Xu , D. Ross Camidge , Shobhit Baijal , Sudeep Karve , Sophia Ng , Rajesh Kamalakar , Christine Ratajczak , Allison Allen , Shun Lu\",\"doi\":\"10.1016/j.jtho.2024.05.293\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086424004982\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086424004982","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
PP01.58 Real-world Outcomes in Patients With EGFR Wildtype Non-squamous Locally Advanced/Metastatic NSCLC Receiving Second- or Third-Line Docetaxel: Pooled Analysis From LUMINATE-101
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.